XML 43 R33.htm IDEA: XBRL DOCUMENT v3.20.2
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)
 9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Schedule of revenue recognition

The Company’s disaggregated revenues consist of the following for the nine months ended September 30, 2020 and 2019:

  

    Nine Months ended September 30, 2020  
    GWW     Coolisys     Ault Alliance     Total  
                         
Primary Geographical Markets                        
North America   $ 5,109,672     $ 3,100,552     $ (27,140 )   $ 8,183,084  
Europe     694,478       288,282       -       982,760  
Middle East     6,837,501       -       -       6,837,501  
Other     264,226       414,407       -       678,633  
    $ 12,905,877     $ 3,803,241     $ (27,140 )   $ 16,681,978  
                                 
Major Goods                                
RF/Microwave Filters   $ 3,886,940     $ —     $ —     $ 3,886,940  
Detector logarithmic video amplifiers     1,318,547       —       —       1,318,547  
Power Supply Units     —       3,803,241       —       3,803,241  
Power Supply Systems     862,889       —       —       862,889  
Healthcare diagnostic systems     784,689       —       —       784,689  
Defense systems     6,052,812       —       —       6,052,812  
Lending activities     —       —       (27,140 )     (27,140 )
    $ 12,905,877     $ 3,803,241     $ (27,140 )   $ 16,681,978  
                                 
Timing of Revenue Recognition                                
Goods transferred at a point in time   $ 6,068,376     $ 3,803,241     $ (27,140 )   $ 9,844,477  
Services transferred over time     6,837,501       —       —       6,837,501  
    $ 12,905,877     $ 3,803,241     $ (27,140 )   $ 16,681,978  

  

    Nine Months ended September 30, 2019  
    GWW     Coolisys     Ault Alliance     Total  
                         
Primary Geographical Markets                        
North America   $ 2,703,803     $ 4,590,840     $ 443,927     $ 7,738,570  
Europe     6,341,396       16,804       —       6,358,200  
Middle East     1,283,312       21,348       —       1,283,312  
Other     447,786       269,440       —       717,226  
    $ 10,776,297     $ 4,898,432     $ 443,927     $ 16,097,308  
                                 
Major Goods                                
RF/Microwave filters   $ 989,114     $ —     $ —     $ 989,114  
Detector logarithmic video amplifiers     473,150       —       —       473,150  
Power supply units     3,194,843       4,306,340       —       7,501,183  
Power supply systems     1,423,971       —       —       1,423,971  
Healthcare diagnostic systems     1,260,700       —       —       1,260,700  
Defense systems     3,413,171       —       —       3,413,171  
Lending activities     —       —       443,927       443,927  
Digital currency mining     —       592,092       —       592,092  
    $ 10,754,949     $ 4,898,432     $ 443,927     $ 16,097,308  
                                 
Timing of Revenue Recognition                                
Goods transferred at a point in time   $ 5,944,177     $ 4,898,432     $ 443,927     $ 11,286,536  
Services transferred over time     4,810,772       —       —       4,810,772  
    $ 10,754,949     $ 4,898,432     $ 443,927     $ 16,097,308  
Schedule of fair value measurement

The following table sets forth the Company’s financial instruments (see Note 5 and Note 9) that were measured at fair value on a recurring basis by level within the fair value hierarchy:

 

    Fair Value Measurement at September 30, 2020  
    Total     Level 1     Level 2     Level 3  
Investments in convertible promissory note of
AVLP – a related party		   $ 7,059,322     $ —     $ —     $ 7,059,322  
Investments in common stock and derivative
instruments of AVLP – a related party		     2,750,580       259,786     $ —       2,490,794  
Investment in common stock and warrants of
Alzamend – a related party		     587,686       —       —       587,686  
Investments in marketable equity securities     386,476       386,476       —       —  
Investments in warrants of public companies     103       —       —       103  
Total Investments   $ 10,784,167     $ 646,262     $ —     $ 10,137,905  

  

    Fair Value Measurement at December 31, 2019  
    Total     Level 1     Level 2     Level 3  
Investments in convertible promissory note of
AVLP – a related party		   $ 6,540,720     $ —     $ —     $ 6,540,720  
Investments in common stock and derivative
instruments of AVLP – a related party		     1,569,286       238,602       —       1,330,684  
Investment in common stock of Alzamend – a
related party		     558,938       —       —       558,938  
Investments in marketable equity securities     639,647       639,647       —       —  
Investments in warrants of public companies     9,174       —       —       9,174  
Total Investments   $ 9,317,765     $ 878,249     $ —     $ 8,439,516  
Schedule of anti-dilutive securities

Anti-dilutive securities, which are convertible into or exercisable for the Company’s common stock, consist of the following at September 30, 2020 and 2019:

 

    September 30,  
    2020     2019  
Stock options     950       2,906  
Warrants (1)     3,582,116       72,921  
Convertible notes     1,396,419       349,486  
Conversion of preferred stock     2,232       2,232  
Total     4,981,717       427,545  

 

  (1) The Company has excluded 6,500 warrants issued in April 2019, which may be exercised by means of a cashless exercise into 6,500 shares of the Company’s common stock, in its anti-dilutive securities but included the warrants in its weighted average shares outstanding.